Group activity
- Veilleux created the group US FDA Expands Use Of Regeneron's Cholesterol Drug In Young ChildrenThe drug, Evkeeza, was approved in February 2021 as an additional treatment with other lipid-lowering therapies for patients aged 12 years and above with homozygous familial hypercholesterolemia (HoFH). manufacturers to Russian buyers, some of...